31
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Gastrointestinal Disturbances with Obesity

, , &
Pages 53-58 | Published online: 08 Jul 2009

References

  • Lichtman S W, Pisarska K, Raynes Berman E, et al. Discrepancy between self-reported and actual caloric intake and exercise in obese subjects. N Engl J Med 1992; 237: 1893–8
  • Ravussin E, Swinburn B A. Pathophysiology of obesity. Lancet 1992; 340: 404–13
  • Müller M J, Lautz H J, von zur Mühlen A, et al. Pathogenese und Therapie der Adipositas: Wie schützen wir uns vor dem Überfluss. Deut Med Wschr 1990; 115: 789–94
  • Clain D J, Lefkowitch J H. Fattv liver disease in morbid obesitv. Gastroenterol Clin N Am 1987; 16: 239–52
  • Andersen T. Liver and gallbladder disease before and after very-low-calorie-diets. Am J Clin Nutr 1992; 56(Suppl 2)S235–9
  • Wanless R, Lcntz J S. Fatty liver hepatitis (steatohepatitis) and obesitv: an autopsv study with analysis of risk factors. Hepa-tology 1990; 12: 1106–10
  • Moran J R, Ghishan F K, Halter S A, et al. Steatohepatitis in obese children: a cause of chronic liver dysfunction. Am J Gastroenterol 1983; 78: 374–7
  • Powell E E, Cooksly E, Warahum F, et al. The natural history of non-alcoholic steatohepatitis: a follow-up of forty-two patients for up to 21 years. Hepatology 1990; 11: 74–80
  • Ranlov I, Hardt F. Regression of liver steatosis following gastroplasty or gastric bypass for morbid obesity. Digestion 1990; 47: 208–14
  • Svedberg J, Stromblad G, Wirth A, et al. Fatty acids in the portal vein of the rat regulate hepatic insulin clearance. J Clin Invest 1991; 88: 2054–8
  • Robinson D, Whitehead T P. Effect of body mass and other factors on serum liver enzyme levels in men attending for well population screening. Ann Clin Biochem 1989; 26: 393–400
  • Brimas G E, Markov V K, Kuzin N M, et al. State of the liver in patients with obesity at distant periods of a ‘small stomach’. Khirurgiia (Mosk) 1991; 11: 88–93
  • Drenick E J, Simmons F, Murphy J F. Effect on hepatic morphology of treatment of obesity by fasting after formation-reducing diets and small-bowel bypass. N Engl J Med 1970; 282: 829–34
  • Palmer M, Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology 1990; 99: 1408–13
  • Eriksson S, Eriksson R F, Bondesson L. Non-alcoholic steatohepatitis in obesity: a reversible condition. Acta Med Scand 1986; 220: 83–8
  • Amaral J F, Thompson W R. Gallbladder disease in the morbidly obese. Am J Surg 1985; 149: 551–7
  • Bennion L J, Grundy S M. Effects of obesity and caloric intake on biliary lipid metabolism in man. J Clin Invest 1975; 56: 996–1011
  • Pomeranz I S, Shaffer E A. Abnormal gallbladder emptying in a subgroup of patients with gallstones. Gastroenterology 1985; 88: 787–91
  • Marzio L, Capone F, Neri M, et al. Gallbladder kinetics in obese patients. Effect of a regular meal and low-calorie meal. Dig Dis Sci 1988; 33: 4–9
  • Stampfer M J, Maclure K M, Colditz G A, et al. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr 1992; 55: 652–8
  • Hopper K D, Landis J R, Meilstrup J W, et al. The prevalence of asymptomatic gallstones in the general population. Invest Radiol 1991; 26: 939–45
  • Silidker M S, Cronan J J, Scola F H, et al. Ultrasound evaluation of cholelithiasis in the morbidly obese. Gastrointestin Radiol 1988; 13: 345–6
  • Broomfield P H, Chopra R, Scheinbaum R C, et al. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight. N Engl J Med 1988; 319: 1567–72
  • Kamrath R O, Plummer L J, Sadur Cn, et al. Cholelithiasis in patients treated with a very-low-calorie-diet. Am J Clin Nutr 1992; 56: 255S–7S
  • Falcon W W. Hepatobiliary effects of obesity and weight reducing surgery. Semin Liver Dis 1988; 8: 229–36
  • Lee S P, Sekijima J. Treatment of gallstones. Textbook of gastroenterology, T Yamada. Lippincott, Philadelphia 1991; 1981–9
  • Mazzella G, Bazzoli F, Festi D, et al. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction. Gastroenterology 1991; 101: 490–6
  • Whiting M J, Hall J C, Lannos J. The cholesterol saturation of bile and its reduction by chenodeoxycholic acid in massively obese patients. Int J Obes 1984; 8: 681–8
  • Gadacz T R, Talamini M A. Traditional versus laparoscopic cholecystectomy. Am J Surg 1991; 161: 336–8
  • Stene-Larsen G, Weberg R, Froyshov Larsen I, et al. Relationship of overweight to hiatus hernia and reflux oesophagitis. Scand J Gastroenterol 1988; 23: 427–32
  • Hagen J, Deitel M, Khanna R K, et al. Gastroesophageal reflux in the massively obese. Int Surg 1987; 72: 1–3
  • Maddox A, Horowitz M, Wishart J, et al. Gastric and oesophageal emptying in obesity. Scand J Gastroenterol 1989; 24: 593–8
  • Lepsien K, Nustede R, Schafmayer A, et al. Does the stomach balloon modify the function of the esophagus and lower esophageal sphincter, stomach emptying and release of gastrointestinal peptides?. Z Gastroenterol 1989; 27: 247–53
  • Zacchi P, Mearin F, Humbert P, et al. Effect of obesity on gastroesophageal resistance to flow in man. Dig Dis Sci 1991; 36: 1473–80
  • Andersen L I, Jensen G. Risk factors for benign oesophageal disease in a random population sample. J Int Med 1991; 230: 5–10
  • O'Brien T F, Jr. Lower esophageal sphincter pressure (LESP) and esophageal function in obese humans. J Clin Gastroenterol 1980; 2: 145–8
  • Backman L, Granstrom L, Lindahl J, et al. Manometric studies of lower esophageal sphincter in extreme obesity. Acta Chir Scand 1983; 149: 193–7
  • Horowitz M, Collins P J, Schearman D JC. Effect of increasing the caloric/osmotic content of the liquid component of a mixed solid and liquid meal on gastric emptying in obese subjects. Hum Nutr Clin Nutr 1986; 40: 51–6
  • Barkin J S, Reiner D K, Goldberg R I, et al. The effects of morbid obesity and the Garren-Edwards gastric bubble on solid phase gastric emptying. Am J Gastroenterol 1988; 83: 1364–7
  • Zahorska-Markiewicz B, Jonderko K, Lelek A, et al. Gastric emptying in obesity. Hum Nutr Clin Nutr 1986; 40: 309–13
  • Gannon M X, Pears D J, Chandler S T. The effect of gastric partitioning on gastric emptying in morbidly obese patients. Br J Surg 1985; 72: 952–4
  • Sasaki H, Nagulesparan M, Dubois A, et al. Gastric function and obesity: gastric emptying, gastric secretion and plasma pepsinogen. Int J Obes 1984; 8: 183–90
  • Horowitz M, Collins P J, Chatterton B E, et al. Gastric emptying after gastroplasty for morbid obesity. Br J Surg 1984; 71: 435–7
  • Geliebter A. Gastric distension and gastric capacity in relation to food intake in humans. Physiol Behav 1988; 44: 665–8
  • Granstrom L, Backman L. Stomach distension in extremely obese and in normal subjects. Acta Chir Scand 1985; 515: 367–70
  • Basilisco G, Camboni G, Bozzani A. Orocecal transit delay in obese patients. Dig Dis Sci 1989; 34: 509–12
  • Pieramico O, Malfertheiner P, Nelson D K, et al. Interdigestive gastroduodenal motility and cycling of putative regulatory hormones in severe obesity. Scand J Gastroenterol 1992; 27: 538–44
  • Peterson H R, Rothschild M D, Weinberg C R, et al. Body fat and the activity of the autonomic nervous system. N Engl J Med 1988; 318: 1077–83
  • Wisén O, Rössner S, Johansson C. Gastric secretion in massive obesity: evidence of abnormal response to vagal stimulation. Dig Dis Sci 1987; 32: 968–72
  • Wisén O, Rössner S, Johansson C. Impaired pancreatico-biliary response to vagal stimulation and to cholecystokinin in human obesity. Metabolism 1988; 37: 436–41
  • Pi-Sunyer X, Kissileff H R, Thornton J, et al. C-terminal octa-peptide of cholecystokinin decreases food intake in obese man. Physiol Behav 1982; 29: 627–30
  • Kissileff H R, Pi-Sunyer X, Thornton J, et al. C-terminal octa-peptide of cholecystokinin decreases food intake in man. Am J ClinNutr 1981; 34: 154–60
  • Stacher G, Steinringer H, Schmiere G, et al. Cholecystokinin octapeptide decreases intake of solid food in man. Peptides 1982; 1: 133–6
  • Romsos D R, Gosnell B A, Morley J E, et al. Effects of kappa opiate agonists cholecystokinin and bombesin on intake of diets varying in carbohydrate-to-fat ratio in rats. J Nutr 1987; 117: 976–85
  • McLaughlin C L, Baile C A. Feeding response of weanling Zucker obese rats to cholecystokinin and bombesin. Physiol Behav 1980; 25: 341–6
  • Flood J F, Silver A J, Morley J E. Do peptide-induced changes in feeding occur because of changes in motivation to eat. Peptides 1990; 11: 265–70
  • McCoy J G, Stump B, Avery D D. Intake of individual mac-ronutrients following ip injections of bombesin and CCK in rats. Peptides 1990; 11: 221–5
  • Glaser B, Zoghlum G, Pienta K, et al. Pancreatic polypeptide response to secretin in obesity: effects of glucose intolerance. Horm Metab Res 1988; 20: 288–92
  • McLaughlin C L, Peikin S R, Baile C A. Decreased pancreatic CCK-stimulated amylase release in Zucker obese rats. Physiol Behav 1984; 32: 961–5
  • Green D W, Comez G, Greeley G H, Jr. Gastrointestinal peptides. Gastroenterol Clin North Am 1989; 18: 695–733
  • Schwartz T W. Pancreatic polypeptide: a hormone under vagal control. Gastroenterology 1983; 85: 1411–25
  • Jia B O, Taylor I L. Failure of pancreatic polypeptide release in congenitally obese mice. Gastroenterology 1984; 87: 338–43
  • Malaisse-Lagre F, Carpenter J L, Patel Y C, et al. Pancreatic polypeptide: a possible role in the regulation of food intake in the mouse. Hypothesis. Experientia 1977; 33: 915–17
  • Gettys T W, Garcia R, Savage R, et al. Insulin-sparing effects of pancreatic polypeptide in congenitally obese rodents. Pancreas 1991; 6: 46–53
  • Zipf W B, O'Dorsisie T M, Cataland K. Pancreatic polypeptide response to protein meal challenges in obese but otherwise normal children and obese children with Prader Willi syndrome. J Clin Endocrinol Metab 1983; 57: 1074–80
  • Marco J, Angelese Zulueta M, Correas I, et al. Reduced pancreatic polypeptide secretion in obese subjects. J Clin Endocrinol Metab 1980; 50: 744–47
  • Lawson M J, Gehling R N, Butler R N, et al. Human pancreatic polypeptide release and gallbladder response after amino acid and cephalic vagal stimuli in obese and non-obese subjects. Med Sci Res 1987; 15: 183–4
  • Lassmann V, Vague P, Vialettes B, et al. Low plasma levels of pancreatic polypeptide in obesity. Diabetes 1990; 29: 428–30
  • Peiris A, Kissebah A. Endocrine abnormalities in morbid obesity. Gastroenterol Clin North Am 1987; 16: 389–98
  • Gramstrom L, Bacham L, Uvnas-Moberg K. Serum gastrin. insulin and somatostatin levels in normal and obese subjects before and after gastric banding. Acta Clin Scand 1988; 154: 117–21
  • Sirinek K R, O'Dorisio T M, Have B, et al. Pancreatic islet hormone response to oral glucose in morbidlv obese patients. Ann Surg 1985; 201: 690–4
  • Schusdziarra V, Lawecki J, Ditschuneit H, et al. Effect of low dose somatostatin infusion on pancreatic and gastric endocrine function in lean and obese non-diabetic human subjects. Diabetes 1985; 34: 395–601
  • Schusdziarra V, Schmid R. Physiological and pathophysiological aspects of somatostatin. Scand J Gastroenterol 1986; 119: 29–41, Suppl
  • Hoist J J, Schwartz T W, Lovgreen N A, et al. Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity. Int J Obes 1983; 7: 529–39
  • National Institutes of Health Consensus Development Conference Statement. Health Implications of Obesity. Ann Intern Med 1985; 103: 147–51
  • Kune G A, Kune S, Watson L F. Report: Body weight and physical activity as predictors of colorectal cancer risk. Nutr Cancer 1990; 13: 9–17
  • Phillips R L, Snowdon D A. Dietary relationships with fatal colorectal cancer among seventh-day adventists. J Natl Cancer Inst 1985; 74: 307–17
  • Graham S, Marshall J, Haughey B, et al. Dietary epidemiology of cancer of the colon in western New York. Am J Epidemol 1988; 128: 490–503
  • Suadicani P, Hein H O, Gyntelberg F. Height, weight, and risk of colorectal cancer: an 18-year follow-up in a cohort of 5249 men. Scand J Gastroenterol 1993; 28: 285–8
  • Bayerdörffer E, Mannes G A, Ochsenkühn T, et al. Increased risk of ‘high-risk’ colorectal adenomas in overweight men. Gastroenterology 1993; 104: 137–44
  • Bayerdörffer E, Mannes G A, Richter W O, et al. Increased serum deoxycholic acid levels in men with colorectal adenomas. Gastroenterology 1993; 104: 145–51
  • Shicke M, Minawer S J, Greenwald P H, et al. Primary prevention of colorectal cancer. Bull WHO 1990; 68: 377–85
  • Pi-Sunyer X F. The role of very-low-calorie-diets in obesity. Am J Clin Nutr 1992; 56: S240–3
  • Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr 1992; 55: 615S–9S
  • Lerman R H, Cave D R. Medical and surgical management of obesity. Avd Intern Med 1989; 34: 127–64
  • Marcuard S P, Sunar D R, Swanson M S, et al. Absence of luminal intrinsic factor after gastric bypass surgery for morbid obesity. Dig Dis Sci 1989; 34: 1238–342
  • Wayman C S, Nord H J, Combs W M, et al. The role of endoscopy after vertical banded gastroplasty. Gastrointest Endosc 1992; 38: 44–6
  • Sataloff D M, Lieber C P, Seinige U L. Strictures following gastric stapling for morbid obesity. Results of endoscopic dilatation. Am Surg 1990; 56: 167–74
  • Radjeo J, Bhuta K, Ackerman N B. Endoscopic management of gastric outlet obstruction following surgery for morbid obesity. Am Surg 1989; 55: 724–7
  • Faber L A, Maher J W, Mason E E. Balloon dilatation of gastro-gastrostomy strictures in gastroplasty revision. Am Surg 1989; 55: 105–10
  • Thrilby R C. Jejunoileal bypass: can the mistake be corrected. Gastroenterology 1990; 98: 1710–1
  • Palmer M, Schaffner F, Thung S N. Excessive weight gain after liver transplantation. Transplantation 1991; 51: 797–800
  • Fulton J D, Peebles S E, Smith G D, et al. Unrecognized viscus perforation in the elderly. Age Ageing 1989; 18: 403–6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.